Navigation Links
New Drug That Might Help Congestive Heart Failure Patients

Most patients with congestive heart failure respond to standard treatments, which include diuretics, ACE inhibitors and beta-blockers. However, nearly 30 percent of these patients return to the hospital //within two months, and some of the medications can cause serious side effects such as electrolyte abnormalities and worsening kidney function. Researchers say a new drug Tolvaptan may be more effective than existing medications for treating patients with congestive heart failure.

Patients are usually hospitalized because of fluid retention, which occurs when the body overcompensates for a weak heart. When the heart struggles to beat efficiently, the brain produces a hormone called vasopressin, which constricts blood vessels and causes fluid retention. Researchers studied Tolvaptan -- a drug that targets vasopressin -- to determine if it effectively reduces fluid retention.

More than 300 patients with severe heart failure participated in the study. Researchers divided the participants into four groups and followed them for seven weeks. Patients received either 30 milligrams, 60 milligrams or 90 milligrams of Tolvaptan or a placebo in addition to standard medications. Results of the study showed patients who took Tolvaptan weighed less within 24 hours, indicating a decrease in fluid retention. The mortality rate was also lower for those in the Tolvaptan group. Researchers say there were no changes in worsening heart failure between the groups at 60 days.

Based on the results of the above study researchers conclude saying that they now have an agent that appears promising and safe.
'"/>




Page: 1

Related medicine news :

1. Anemia Treatment for Cancer Patients Might Not be a Good Idea.
2. Tomatoes Might Inhibit the Development Of Prostate Cancer
3. Mad Cow Disease Might Be Linked to Blood Transfusions
4. Strategies That Might Lower Blood Pressure Questioned
5. Factors That Might Increase The Risk Of Schizophrenia
6. A Drug That Might Relieve Chronic Cough
7. Biochemical Markers Might Help Predict Heart Problems
8. Yoga Might Be Helpful For Cancer Patients
9. Healthcare Professionals Might Want To Rethink Their Dress Code
10. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
11. Counting Calories Might Be The Ideal Way To Stay Healthy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... Vegas, NV (PRWEB) , ... April 25, 2017 ... ... can now choose a modern procedure that achieves results in a fraction of ... in Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary ...
(Date:4/25/2017)... GA (PRWEB) , ... April 25, 2017 , ... ... their neck and back pain with a reputable physician in their area, announces the ... CRM protects patient information for patients who are looking for reputable physicians to help ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical ... patients in Nashville , Tennesse have ... Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. The ... provide long-term reflux control by restoring normal function to ... 65 million people in the United States ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
Breaking Medicine Technology: